Results 221 to 230 of about 38,780 (255)
Some of the next articles are maybe not open access.
Detection of antibodies to human T‐lymphotropic virus type 1 (HTLV‐1)
Transfusion, 1988Sera from 39,898 blood donors were tested for HTLV‐1 antibodies using two enzyme immunoassays (EIA). Sera testing initially reactive (IR) were retested in duplicate by both EIAs. Sera testing repeatedly reactive (RR) were further tested by two Western blots (WB) and by two radioimmunoprecipitation assays (RIPA).
C T, Fang +4 more
openaire +2 more sources
Human T-Lymphotropic Virus type 1 infective dermatitis in central Australia
Journal of Clinical Virology, 2013The Human T-Lymphotropic Virus type 1 (HTLV-1) is a single-stranded RNA retrovirus that preferentially infects CD4+ T cells. The spectrum of diseases that are associated with the most frequent genotype, the HTLV-1 cosmopolitan subtype A, has been well described.
Einsiedel, Lloyd +3 more
openaire +3 more sources
Archives of Virology, 2001
Phenotypic change and broader coreceptor usage by HIV-1 have been associated with disease progression. HIV-1 coreceptor usage by primary isolates obtained from HIV-1-infected and HIV-1/HTLV-II-coinfected individuals was determined. HIV-1 was isolated from 15 of 20 HIV-1-infected and 17 of 24 HIV-1/HTLV-II-coinfected individuals.
P C, Guenthner +3 more
openaire +2 more sources
Phenotypic change and broader coreceptor usage by HIV-1 have been associated with disease progression. HIV-1 coreceptor usage by primary isolates obtained from HIV-1-infected and HIV-1/HTLV-II-coinfected individuals was determined. HIV-1 was isolated from 15 of 20 HIV-1-infected and 17 of 24 HIV-1/HTLV-II-coinfected individuals.
P C, Guenthner +3 more
openaire +2 more sources
Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
International Journal of Hematology, 2003The human retrovirus human T-lymphotropic virus type 1 (HTLV-1) is associated with two distinct types of disease: the malignancy known as adult T-cell leukemia and a range of chronic inflammatory conditions including the central nervous system disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
openaire +2 more sources
Inhibition of Apoptosis by Human T‐Lymphotropic Virus Type‐1 Tax Protein
Annals of the New York Academy of Sciences, 2003Abstract: Deregulation of the apoptotic process can lead to pathophysiological changes that result in either degenerative diseases or cancer. Although the transactivator Tax has been established as an essential effector of human T‐lymphotropic virus type‐1 (HTLV‐1)‐mediated diseases, which include both a neurodegenerative pathology and leukemia ...
Daniela, Saggioro +3 more
openaire +2 more sources
Human T-Lymphotropic Virus Type 1 (HTLV-1)–Associated Diseases
2008Abstract HTLV-1 causes two distinct types of disease: an aggressive leukemia of CD4+ T-cells, known as adult T-cell leukemia (ATL), and a range of chronic inflammatory diseases, of which HTLV-1–associated myelopathy=tropical spastic paraparesis (HAM=TSP) is the best studied.
openaire +1 more source
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Cervical cancer prevention and control in women living with human immunodeficiency virus
Ca-A Cancer Journal for Clinicians, 2021Philip E Castle, Vikrant V Sahasrabuddhe
exaly
Neurological Manifestations of the Human T-lymphotropic Virus Type 1
2017The human T cell lymphotropic virus type 1 (HTLV-1) is a retrovirus that infects about 20 million individuals worldwide. Its typical neurological presentation is of a chronic, slowly progressive myelopathy named “HTLV-1-associated myelopathy/tropical spastic paraparesis” (HAM/TSP).
openaire +1 more source